Women's Global Impact Forum 2025: Former Pepsi CEO on Juggling Career and Family
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
"There's a lot of women who serve as the backbone of the country."
That was one of the closing lines from Indra K. Nooyi, former chairman and CEO of PepsiCo, at Newsweek's inaugural Women's Global Impact Forum on Tuesday, August 5, 2025, at Newsweek's headquarters in New York City.
The one-day event, sponsored by MyEyeDr., with partners Starz and TriNet, brought together 300 senior executives and rising stars across multiple industries to celebrate the achievements women have made, connect with inspiring women and find practical solutions to overcome some of the biggest challenges they still face in the workplace.
On the stage, leaders from companies like the WNBA, SoulCycle, Nissan, Samsung, Hulken, Coach, Estée Lauder and Girl Scouts of the USA shared personal anecdotes about their professional journeys and the struggles of being women in the workplace.
Chloe Coscarelli, Allison Stransky, Tanya Taylor and Nicole Wegman speak on the "Fostering Creativity While Impacting the Bottom Line" panel during the Women's Global Impact forum on Tuesday, August 5, 2025, at the One World...
Chloe Coscarelli, Allison Stransky, Tanya Taylor and Nicole Wegman speak on the "Fostering Creativity While Impacting the Bottom Line" panel during the Women's Global Impact forum on Tuesday, August 5, 2025, at the One World Trade Center in New York City. More
Weston Kloefkorn | For Newsweek
While the conversations noted the unique challenges for industries like sports, fashion, retail, beauty, tech and health care, the women on and off stage found common ground. Most of the women in the room have experienced discrimination, failures, company reconstruction and imposter syndrome.
At the core of the conversations, each speaker exemplified what it means to be a strong and effective leader today and in the future.
Prioritizing wellness
During the "Prioritizing Wellness" panel, speakers agreed that good leaders take their wellness seriously.
Sakara co-founder Danielle DuBoise stressed the importance of "checking your engine light" by listening to your body to prevent burnout.
"So I'd say the first thing is to really get to this place where you can tell when your body is listening," she said. "And then second is, once you listen, like I know my throat gets a little funky, I say to myself, 'OK, I need more rest. I need more greens and plants, or I just needed to tap out for a little bit.'"
Sakara co-founder Danielle DuBoise joined WeightWatchers CMO Kim Boyd and SoulCycle CEO Evelyn Webster for the 'Prioritizing Wellness Makes Us More Impactful' panel during the Women's Global Impact forum on Tuesday, August 5, 2025.
Sakara co-founder Danielle DuBoise joined WeightWatchers CMO Kim Boyd and SoulCycle CEO Evelyn Webster for the 'Prioritizing Wellness Makes Us More Impactful' panel during the Women's Global Impact forum on Tuesday, August 5, 2025.
Weston Kloefkorn | For Newsweek
SoulCycle CEO Evelyn Webster said leaders "set the weather" for their organizations, so it's important to be consistent.
"I can tell when I'm not investing in my own wellness because of the way that I start to set the temperature in the organization, and that's not a good thing."
"Over time, when I invested in my wellness, I'm happy and a better human," she said. "When you're healthy, you are happy and we all deserve to be happy."
As the leader of an exercise company, she sees every day how endorphins make her clients and instructors happier, think clearly, communicate better and help enable them to better lead and inspire.
Seeking out and being a mentor
Mentorship was an essential tenet that has allowed many of the women to thrive/climb the corporate ladder.
Girl Scouts of the USA CEO Bonnie Barczykowski said it best on the "Shaping an Equitable Future" panel: "Girls achieve what they can see."
Girl Scouts USA CEO Bonnie Barczykowski listens to an audience questions during the "Women at Work: Shaping an Equitable Future" panel at the Women's Global Impact forum on Tuesday, August 5, 2025.
Girl Scouts USA CEO Bonnie Barczykowski listens to an audience questions during the "Women at Work: Shaping an Equitable Future" panel at the Women's Global Impact forum on Tuesday, August 5, 2025.
Weston Kloefkorn | For Newsweek
Allyson Witherspoon, the chief marketing officer of Nissan U.S., said on the "Leadership: The New Measures of Success" that she is grateful for the many male mentors she's had who took a chance on her throughout her career.
But it wasn't until she worked with a female CEO that she said she began to "understand what it took to be a leader like that, and then what it's like to be a woman in that role."
"This was the first time that I saw somebody, I kind of thought, maybe I can be in a leadership position too," she said.
Clinique and Dermatological Brands general manager Kelly Fanning shared how her parent company, Estée Lauder, has a "reverse mentorship" where junior executives mentor senior leadership. Through that, Fanning said she learned how to look at TikTok, Sephora shopping and AI tools in new ways.
"So the reverse network has been awesome," she said. "It's fun to be able to see that executive level, you're still learning."
Using experience from other jobs
Both on stage and in the audience, the women in attendance share a lifetime of experiences. But, as with many successful people, their journeys were not linear. Whether it's a promotion or a complete industry change, a good leader can take all their cumulative experiences and skills and bring them into a new role.
Those soft skills or traditionally female skills have often been seen as a detriment in the workplace, but the women at this event said it is those very things that have allowed them to succeed.
As she built the optometry network MyEyeDr., Sue Downes recognized that women tend to be more attentive to others' behaviors and have more compassion for other people's needs. She told the audience that being a leader doesn't mean forgetting who you are as women.
"Don't be afraid to be a really great mom," she advised. "If I'm in a board meeting and my child calls, I'm excusing myself. Do what you want to do and don't be judged by anyone else."
WNBA Commissioner Cathy Engelbert speaks with Newsweek Editor-in-Chief Jennifer Cunningham for a fireside chat during the Women's Global Impact forum on Tuesday, August 5, 2025, at the One World Trade Center in New York City.
WNBA Commissioner Cathy Engelbert speaks with Newsweek Editor-in-Chief Jennifer Cunningham for a fireside chat during the Women's Global Impact forum on Tuesday, August 5, 2025, at the One World Trade Center in New York City.
Weston Kloefkorn | For Newsweek
Before she was the commissioner of the WNBA, Cathy Engelbert was the first female CEO of Deloitte. When she made the jump from consulting to sports, she said she was apprehensive at first because she knew "nothing about being a commissioner running a sports league."
"I've been a CPA. I've been an accountant. I've worked in the pharma industry. I worked in banking clients. I've worked in consumer products, but I don't know anything about running sports," she said.
But after landing the position, she quickly found that a lot of her skills were transferable – including strategy planning to take care of players, fans and shareholders, scenario planning during the draft in the COVID-19 pandemic and executive marketing to transform an under-resourced team into a league with over 100 million fans.
Listening and delivering on stakeholder needs
A good leader is one who listens – to colleagues, customers and trends. This includes leaning into trends that align with company values and goals and starting from a place of learning in the boardroom.
Hulken CEO Alex Schinasi also talked about how her bag company turned the "really unsexy" task of schlepping things around into New York City's hottest accessory. From makeup artists to grandmas getting groceries to moms carpooling to soccer practice – Hulken thrives on user-generated content and authentic reviews.
"Shlepping is universal," she said. "By leaning into that, we actually created a sense of authenticity, of honesty, that our audience can really relate to. So this feeling of relatability is actually hugely impactful."
Newsweek weekend reporter Mandy Taheri moderates the "Redefining the Market: How Women in Business Are Transforming Consumer Engagement" panel during the Women's Global Impact forum on Tuesday, August 5, 2025 at the One World Trade...
Newsweek weekend reporter Mandy Taheri moderates the "Redefining the Market: How Women in Business Are Transforming Consumer Engagement" panel during the Women's Global Impact forum on Tuesday, August 5, 2025 at the One World Trade Center in New York City. Panelists include NFL VP Sarah Bishop, Hulken president Alex Schinasi and Coach Collaborations and Coachtopia SVP Jennifer Yue. More
Weston Kloefkorn | For Newsweek
When entering a new company or board, it is also crucial to observe and learn as much about the company as possible from the jump.
Bridget Ryan Berman, member of the board of directors of the Asbury Automotive Group, Newell Brands and Tanger Inc., spoke on the "Women on Boards" panel about how making an impact comes in a variety of forms and strengthens with time and experience. Good leaders, she said, don't lead with ego.
"Oftentimes, people try to oversell themselves," she said. "You see that often in a boardroom, you read about people who come in and they want to take the oxygen around the room," she said. "It's really about becoming a student of that company and of the business and the industry they're in and leaning into that really from day one."
Deconstruct the myth of having it all
Finally, in a room of accomplished and powerful women, there is a lingering pressure to "have it all." But at the final chat of the day, Indra Nooyi shut down the myth of being perfect.
"You can't just be average at being a mother, average in being a wife and average at being an executive ... you've got to be good at the job, and the burden falls on us [women]," she said. "So I look at all this and say, we are lying to women that you can have it all. Let's be honest and say it's that difficult. It's a juggling act. Just hope the most important balls don't drop."
Part of deconstructing the expectation of having it all is being authentic, even when things are tough.
Melody Lee, chief marketing officer at Mercedes-Benz USA, said in the leadership panel that she wished the previous generation of working women could have been more vulnerable and honest about when they failed.
"Women before felt pressure not to see the cracks... but it's not a linear path," she said.
Former PepsiCo CEO Indra K. Nooyi and Newsweek Editor-in-Chief Jennifer Cunningham debunk the myth of "having it all" during the Women's Global Impact forum on Tuesday, August 5, 2025, at the One World Trade Center...
Former PepsiCo CEO Indra K. Nooyi and Newsweek Editor-in-Chief Jennifer Cunningham debunk the myth of "having it all" during the Women's Global Impact forum on Tuesday, August 5, 2025, at the One World Trade Center in New York City. More
Weston Kloefkorn | For Newsweek
Dismantling norms is not only reserved for the office – women are also working to get rid of stigmas about their health and bodies.
During the "Female Founders: Navigating the Entrepreneurial Ecosystem" panel earlier in the day, Megababe founder Katie Sturino shared how her own struggles with body acceptance and thigh chafing inspired the launch of her company that aims to alleviate the physical problems women face but are often too embarrassed to discuss.
Additionally, both Dr. Jessica Shepard, the chief medical officer of Hers, and Jannine Versi, co-founder and CEO of Elektra Health, discussed how there is still a lot of shame and a lack of information surrounding menopause.
By being authentic, attentive, adaptable and open to building connections, women in all industries and experience levels can thrive in the workplace. Women have made incredible strides in the professional world, but there is much work to be done. And hopefully, the women at the Women's Global Impact Forum were inspired enough to take these lessons back to their organizations and start fostering change.
As Girl Scouts of the USA CEO Bonnie Barczykowski put it in a statement to Newsweek, "If the energy in the room is any indication of mobilizing change – we're on our way!"
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
6 hours ago
- Newsweek
Dairy Queen Announces Major Menu Change Starting This Month
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Dairy Queen revealed its highly anticipated fall 2025 menu lineup, reintroducing the popular Pumpkin Pie Blizzard and debuting two desserts for customers nationwide. The new menu is set to launch across participating U.S. locations on August 29, for a limited time. Why It Matters Dairy Queen's seasonal menu updates have become a widely anticipated event, as the fast-food industry heightens its focus on limited-time flavors that help drive customer visits as seasons change. With ongoing competition from major brands like Krispy Kreme and Starbucks, which have both already announced pumpkin-inspired fall offerings, Dairy Queen aims to capture early fall attention and reinforce customer loyalty. Patrons are shown at a Dairy Queen restaurant amid the coronavirus pandemic, on May 25, 2020, in Williams, Arizona. Patrons are shown at a Dairy Queen restaurant amid the coronavirus pandemic, on May 25, 2020, in Williams, To Know The return of the Pumpkin Pie Blizzard, a dessert introduced in 1991, underscores the nostalgic appeal that has become a staple of fast-food seasonal menus. It has been consistently popular among Dairy Queen customers. The seasonal offering combines soft serve with pieces of real pumpkin pie and is finished with whipped cream and a sprinkle of nutmeg. Despite past years including other notable Blizzards, like the Oreo Fudge Brownie and Reese's Peanut Butter Cup Pie, the 2025 fall menu focuses on the Pumpkin Pie Blizzard as its main returning feature. Dairy Queen Reveals Two New Desserts Dairy Queen's 2025 Fall Treat Collection also features two brand-new items: Caramel Toffee Cookie Blizzard: This treat combines Dairy Queen's traditional soft serve with chewy cookie pieces, rich caramel and toffee. This treat combines Dairy Queen's traditional soft serve with chewy cookie pieces, rich caramel and toffee. Maple Cookie Shake: The shake features a maple cookie crumble base blended with soft serve and real milk, topped with whipped cream for a seasonal finish. The fall desserts will also be released nationwide at participating Dairy Queen locations on August 29. The company said these flavors will only be available for a limited time and encourage customers to visit stores before supplies run out. Current summer classics, including the Dipped Strawberry Cheesecake Blizzard and S'mores Blizzard, remain available for those not ready to welcome fall just yet. Newsweek reached out to Dairy Queen for comment via email. What People Are Saying Kevin Thompson, CEO of 9i Capital Group and host of the 9innings podcast, told Newsweek: "The fast-food industry continues to face rising costs, especially for staples like meat and chicken. To offset this, chains are leaning into higher-margin products. Ice cream and dessert items, like Dairy Queen's Blizzards, offer better profitability while also tapping into nostalgia. By bringing back fan favorites, Dairy Queen isn't just appealing to sentiment. It's strategically boosting margins in a challenging cost environment." Alex Beene, financial literacy instructor for the University of Tennessee at Martin, told Newsweek: "There's more to this strategy than Dairy Queen cashing in on the pumpkin craze so many other retailers do as the fall months approach. Dairy Queen, like other fast food restaurants, are pushing new menu items in an attempt to win back customers who have stopped eating out as much to save money. The hope is these new items can generate a buzz, increase foot traffic, and ultimately produce more sales." What Happens Next Dairy Queen's 2025 Fall Treat Collection officially rolls out August 29 at participating locations nationwide, remaining on menus for a limited time while supplies last.
Newsweek
10 hours ago
- Newsweek
Donald Trump Threatens 250% Tariff on Pharmaceuticals
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. President Donald Trump has said that tariffs on pharmaceutical imports could eventually reach up to 250 percent, as his administration works to lower prescription prices for Americans. During an interview with CNBC on Tuesday, the president said he will initially impose a "small tariff on pharmaceuticals," which will rise to 150 percent "in one year, one and a half years maximum," before then eventually jumping to 250 percent. Newsweek reached out to the White House via email for comment. Why It Matters The United States imports a significant amount of pharmaceuticals each year—over $200 billion in 2024, according to the Observatory of Economic Complexity. Should Trump follow through on ramping up these duties, the highest he has threatened on the industry to date, experts believe this could result in significant increases to drug prices in the U.S. However, some health policy experts told Newsweek this could also help rebalance the global drug supply chain to better favor American customers. What To Know Trump said that the tariffs are intended to encourage pharmaceutical companies to move their operations to the U.S.—"because we want pharmaceuticals made in our country"—and to minimize reliance on Europe. He had previously threatened to place 200 percent tariffs on pharmaceuticals in July, but said he would give the industry time before this change came into effect. Trump's threats of pharmaceutical tariffs have raised concerns among experts that these could lead to increased costs and medication shortages in the U.S. In April, the UNC Center for the Business of Health published a report warning that these effects would be especially significant for generic drugs, which are more likely to be imported and operate on lower profit margins than brand-name medications. "A 250 percent tariff on pharmaceuticals would have a significant impact on drug prices," said health economist Jeromie Ballreich. Ballreich told Newsweek that, for branded pharmaceuticals, higher costs from the tariffs will be "passed on to consumers and most likely will be indirect through higher prescription drug insurance premiums." Major pharmaceutical companies across the world saw their shares fall on Wednesday following Trump's announcement. England-based AstraZeneca was down by 1.1 percent, Indiana-based Eli Lilly by 2.3 percent, and Germany-based Bayer AG by nearly 10 percent as of 11:20 ET. President Donald Trump speaks to reporters near Air Force One at Lehigh Valley International Airport on August 3, 2025. President Donald Trump speaks to reporters near Air Force One at Lehigh Valley International Airport on August 3, latest threat comes as the industry braces for the outcome of an ongoing probe by the Commerce Department into the national security implications of America's medicinal imports. The investigation was launched in April by Commerce Secretary Howard Lutnick under Section 232 of the 1962 Trade Expansion Act. Trump did not provide many specifics, such as whether certain classes of pharmaceuticals would be exempt, beyond stating that these tariffs are separate from the country-specific duties that came into effect last week. However, the announcement appears to contradict the terms of the European Union deal struck in July, which the European Commission president said placed a 15-percent tariff "ceiling" on multiple sectors, including pharmaceuticals. Experts had already warned that the 15 percent tariff outlined in the EU trade deal could end up costing the pharmaceutical industry billions. The cost implications could also be seen as conflicting with the administration's separate attempts to lower the price of prescription drugs. President of the European Commission Ursula von der Leyen meets with President Donald Trump in Turnberry, Scotland, on July 27, 2025. President of the European Commission Ursula von der Leyen meets with President Donald Trump in Turnberry, Scotland, on July 27, May, Trump signed an executive order directing the Secretary of Commerce and U.S. Trade Representative to "ensure foreign countries are not engaged in practices that purposefully and unfairly undercut market prices and drive price hikes in the United States." It also proposed that the U.S. be given Most-Favored-Nation (MFN) status, which would require drug companies to offer Americans the same lowest price that drugs are sold for in other countries. Trump followed this up by sending letters to 17 of the world's largest pharmaceutical companies on July 31, outlining steps they must take within 60 days to lower prescription prices for U.S. customers. These include extending MFN pricing to Medicaid, guaranteeing MFN pricing for new medications and negotiating "harder with foreign freeloading nations." The letters also call on the companies to expand direct-to-consumer distribution models to ensure customers "get the same low MFN prices that manufacturers already offer to third-party payers." "At face value, these tariffs are contradictory to his efforts to lower domestic prices," Ballreich told Newsweek. "However, if the tariffs are used as a threat to get drug companies to comply to his administration's [executive orders], including the recent letters to pharmaceutical CEOs, then I think we could see some changes to the pharmaceutical market, which will lower domestic drug prices." Several drugmakers, including Eli Lilly, AstraZeneca and Johnson & Johnson, have also pledged to expand their U.S. manufacturing presence. Prior to the letters being sent, but amid this pressure from the administration, a number had also announced they would be reducing some U.S. drug prices. Health policy analyst Mariana Socal warned that beyond potential cost implications, the tariffs could significantly disrupt the drug development pipeline, potentially jeopardizing the release of new medications. "Aside from the problem of added costs, the uncertainty introduced by tariff policies is detrimental in and of itself to the pharmaceutical market," she told Newsweek, noting that only around one in 10,000 investigated compounds make it to pharmacy shelves, and only do so after decades of work. "Any added uncertainty is likely to be detrimental to this industry, including disincentivizing investors from supporting this industry and pharmaceutical manufacturers from continuing to look for cures," she said. What People Are Saying Health economist Jeromie Ballreich told Newsweek: "This tariff could really disrupt the U.S. prescription drug market, especially the Medicare part D market, where the party plans will be on the hook for the higher price prices and result in significant premium increases to offset these higher prices. Given that, I don't think it's likely that this massive tariff will occur, but rather is a threat to force companies to find solutions based on the executive orders and his recent letters to pharmaceutical CEOs." Mariana Socal, an associate professor at the Johns Hopkins Bloomberg School of Public Health, told Newsweek: "It is critical to continue to identify solutions to lower drug prices in America and improve drug affordability for Americans. However, it is unclear how tariffs would advance affordability. On the opposite, tariffs can be understood as a hidden tax." "In the short term, the likelihood that added costs from tariffs will be passed through to consumers can be reduced by existing contractual agreements with supply chain participants such as distributors and group purchasing organizations, which can protect buyers from price increases for 1-3 years," she added. "However, even if the added cost of tariffs would not necessarily be passed-through to patients in the short term, it could raise costs in the long run." What Happens Next On Sunday, Trump said he would be announcing tariffs on the industry "within the next week or so."
Black America Web
13 hours ago
- Black America Web
Whiskey Industry Shifts In Kentucky, With Some Distillers Declaring Bankruptcy
Kentucky has long hedged its bets on its revered whiskey industry, which, according to the Kentucky Distillers' Association, brings in around $9 million a year. With the whiskey industry shifting along with changing habits of imbibers, some Kentucky distillers have declared bankruptcy, while others are reporting slowed sales. A new report from Newsweek highlighted some of the struggles the whiskey industry in Kentucky is facing of late, emphasizing the financial woes of Luca Mariano Distillery, which just filed for Chapter 11 under its LMD Holdings business name. The outlet, speaking with the Distilled Spirits Council of the United States, obtained a statement from the association, which reads in part that the 'hardships facing distilleries are not unique to those just in Kentucky.' The statement rings true as there has been a trend among the younger generations of abstaining from drinking and preferring a 'dry' lifestyle by ditching booze, sometimes in favor of going 'California Sober,' which points to the ingestion of THC-based drinks. The non-alcoholic drink trend, also widely stylized as NA drinks, has exploded as a category over the past few years. We care about your data. See our privacy policy. According to the publication, Luca Mariano Distillery launched its operation just this past June and is housed on a 553-acre estate in the town of Danville. Francesco Viola, the brand's owner, told a local outlet, the Lexington Herald-Leader , that the filing is a strategy to solidify long-term success for the distillery. Other companies, such as Garrard County Distilling, are struggling as well after it was reported that the Lancaster-based brand was put under receivership and shuttered its operations in 2024. A Google search shows that the distillery is temporarily closed, but little else has been revealed about its future. Stoli Group USA, which produced the award-winning Kentucky Owl whiskey brand, filed for bankruptcy last year, as reported in great detail by Whiskey Advocate here. In a statement to Newsweek , the Distilled Spirits Council shared that the shakeup occuring right now for the Kentucky whiskey business has hit spirits producers of all sorts, hampered by rising costs for materials to produce the priduct, a drop in sales since the boom of the COVID-19 pandemic, and the looming threat of President Donald Trump's tariff policies that have halted trade and export between Canada and other nations that often purchase American spirits in bulk. — Photo: SEE ALSO Whiskey Industry Shifts In Kentucky, With Some Distillers Declaring Bankruptcy was originally published on
